BioCryst Pharmaceuticals Inc (BCRX) stock saw a decline, ending the day at $7.64 which represents a decrease of $-0.09 or -1.16% from the prior close of $7.73. The stock opened at $7.64 and touched a ...

Trump’s early health orders signal plans to reverse Biden policies on drug prices and Medicaid. Experts predict more ...

The Kokomo woman was prediabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed ...

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

Analysts at William Blair upped their FY2024 earnings estimates for Apellis Pharmaceuticals in a report issued on Tuesday, January 21st. William Blair analyst L. Hanbury-Brown now forecasts that the ...

President Trump signed a sweeping order that will reverse several Biden-era executive orders aimed at lowering drug prices.

Trump dismissed the order as part of what he called Biden’s “unpopular, inflationary, illegal, and radical practices.” ...

What To Know About Trump’s Executive Orders on US Health Care From rolling back drug pricing policies to limiting gender-affirming care, President Donald Trump signed several health-related executive ...

Although Trump has said the sweeping crackdown would bring down inflation – by reducing demand for housing and jobs – ...

The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.

Health programs were among the subjects of a flurry of executive orders signed by President Donald Trump soon after his inauguration.

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...